Navigation Links
Pinpointing genes that control breast cancer key in finding treatments
Date:9/20/2012

EAST LANSING, Mich. As scientists continue to map breast cancer's complex genetic makeup, research at Michigan State University could lead to better diagnoses and new treatment targets.

Eran Andrechek in the Department of Physiology has been awarded a $1.5 million National Cancer Institute grant to understand why when a gene known as a transcription factor is removed from a certain type of breast cancer, tumors are delayed and the cancer's ability to spread is vastly reduced.

In about 25-30 percent of all breast cancer cases, a gene known as HER2 is "turned on," or amplified. But given that Herceptin, the most widely used drug to treat HER2 breast cancer, is effective in at most half of these patients, researchers are on the hunt for new treatments.

Andrechek is zeroing in on the E2F family of transcription factors genes that control when other genes are turned "on" or "off."

"When we look at human breast cancer patients, specifically HER2 patients, we can split them up in various groups: Some have good prognosis and respond to treatment and others don't," he said. "We need to understand why that happens.

Down the line, this type of research can have an impact on how we diagnose breast cancer and hopefully lead to better treatments."

Using bioinformatics, or computer technology applied to biological data, Andrechek and his team have shown the E2F transcription factor is active in HER2 cancers, and when it is not active, the cancer's ability to spread is vastly reduced. With the new grant, the next steps are:

  • To completely characterize the effects of removing E2F from a mouse model of HER2 cancer.
  • Determine how the changes occur once the E2F gene is removed.
  • Explore if those same mechanisms are the same in human breast cancer cases

"Since drugs such as Herceptin are only effective in 50 percent of HER2 patients, we need to know if the E2F gene is responsible for that," Andrechek said. "Given the survival differences within patients with HER2 breast cancer, there is a compelling need to understand the genetic makeup of those tumors."


'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert  

Related medicine news :

1. Researchers ID Genes That May Determine Mental Illness
2. 2 repressor genes identified as essential for placental development
3. Genes Associated With Autism Also Related to Schizophrenia
4. Genes Might Cause Some to Shun Pork
5. Blond Genes May Vary Around the World
6. Mystery of the missing breast cancer genes
7. Living longer - variability in infection-fighting genes can be a boon for male survival
8. Genes Might Be Key to Parkinsons Spread
9. Strategy discovered to activate genes that suppress tumors and inhibit cancer
10. Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk
11. Obesity genes may influence food choices, eating patterns
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pinpointing genes that control breast cancer key in finding treatments
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
Breaking Medicine Technology: